Inhibition effects of a natural inhibitor on RANKL downstream cellular signalling cascades cross-talking

Selection of surgical treatment approaches for cervicothoracic spinal tuberculosis: A 10-year case review

(2018) Ziqi Zhu et al.   PLoS One

Surgical Treatment of Lower Cervical Fracture-Dislocation with Spinal Cord Injuries by Anterior Approach: 5- to 15-Year Follow-Up

(2018) Wenjie Gao et al.   World Neurosurgery

Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines

(2017) Lingbo Kong et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice

(2017) Xiaobin Yang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Myricitrin decreases traumatic injury of the spinal cord and exhibits antioxidant and anti-inflammatory activities in a rat model via inhibition of COX-2, TGF-β1, p53 and elevation of Bcl-2/Bax signaling pathway

(2017) Yang Lei   Molecular Medicine Reports

The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways

(2016) Wen-Chin Chiu et al.   PLoS One

Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways

(2015) Meng Qin et al.   VASCULAR PHARMACOLOGY

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

(2014) Lingbo Kong et al.   BMC Complementary and Alternative Medicine

Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models

(2014) T. Li et al.   HUMAN MOLECULAR GENETICS

Emodin Regulates Bone Remodeling by Inhibiting Osteoclastogenesis and Stimulating Osteoblast Formation

(2014) Ju-Young Kim et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis

(2014) QINQIN SHEN et al.   Molecular Medicine Reports

Pyrroloquinoline Quinone (PQQ) Inhibits Lipopolysaccharide Induced Inflammation in Part via Downregulated NF-κB and p38/JNK Activation in Microglial and Attenuates Microglia Activation in Lipopolysaccharide Treatment Mice

(2014) Chongfei Yang et al.   PLoS One

Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines

(2014) Qiang Huang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Myricitrin protects against peroxynitrite-mediated DNA damage and cytotoxicity in astrocytes

(2013) Wei Chen et al.   FOOD CHEMISTRY

MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5

(2013) Wei Li et al.   INTERNATIONAL IMMUNOLOGY

Oral administration of the flavonoid myricitrin prevents dextran sulfate sodium-induced experimental colitis in mice through modulation of PI3K/Akt signaling pathway

(2013) Raquel Cristina Schwanke et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Pyrroloquinoline Quinine Inhibits RANKL-Mediated Expression of NFATc1 in Part via Suppression of c-Fos in Mouse Bone Marrow Cells and Inhibits Wear Particle-Induced Osteolysis in Mice

(2013) Lingbo Kong et al.   PLoS One

Recent drug approvals from the US FDA and EMEA: what the future holds

(2010) Paolo Pevarello   Future Medicinal Chemistry

Ethyl Acetate Fraction from Cudrania Tricuspidata Inhibits IL-1β-Stimulated Osteoclast Differentiation through Downregulation of MAPKs, c-Fos and NFATc1

(2010) Eun-Gyeong Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-κB activation, osteoclastogenesis and bone resorption

(2009) Liping Wang et al.   BONE

Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation

(2009) Insun Song et al.   FEBS LETTERS

Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation

(2009) Takako Negishi-Koga et al.   IMMUNOLOGICAL REVIEWS

Osteoimmunology: Crosstalk Between the Immune and Bone Systems

(2009) Tomoki Nakashima et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Cholinergic protection via α7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation

(2009) Ethika Tyagi et al.   NEUROCHEMISTRY INTERNATIONAL

Myricitrin as a substrate and inhibitor of myeloperoxidase: Implications for the pharmacological effects of flavonoids

(2007) Flavia Carla Meotti et al.   FREE RADICAL BIOLOGY AND MEDICINE